SCHEMBL319155

SCHEMBL319155

CCC1(O)C(C)OC(c2ccncc2[N+](=O)[O-])CC1OC(C)=O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10278541 1.00 MEN1 (0.30) MEN1KMT2A
SCHEMBL14902743 0.86 MEN1 (0.33) MEN1KMT2A
SCHEMBL14902668 0.86
SCHEMBL1911089 0.85 MEN1 (0.33) MEN1KMT2A
SCHEMBL1911108 0.85 MEN1 (0.33) MEN1KMT2A
SCHEMBL319630 0.85 MEN1 (0.33) MEN1KMT2A
SCHEMBL319188 0.84 PIM1 (0.33)
SCHEMBL319186 0.84 PIM1 (0.33)
SCHEMBL319197 0.84 PIM1 (0.33)
SCHEMBL319187 0.84 PIM1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590968-A1 CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS Novartis AG (CH) 2013-05-15 EP disclosed
WO-2012004217-A1 CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS NOVARTIS AG (CH) 2012-01-12 WO disclosed